Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.95
+0.08 (0.62%)
At close: Dec 26, 2025, 4:00 PM EST
13.01
+0.06 (0.46%)
After-hours: Dec 26, 2025, 7:55 PM EST
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $4.07 billion as of December 26, 2025. Its market cap has increased by 61.21% in one year.
Market Cap
4.07B
Enterprise Value
6.55B
1-Year Change
61.21%
Ranking
Category
Stock Price
$12.95
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from $1.91B to $4.07B, an increase of 113.52%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 4.07B | 65.89% |
| Dec 31, 2024 | 2.45B | 31.88% |
| Dec 29, 2023 | 1.86B | 517.28% |
| Dec 30, 2022 | 301.44M | -57.87% |
| Dec 31, 2021 | 715.49M | 6.05% |
| Dec 31, 2020 | 674.66M | 4.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |